As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

Bayesian methods have emerged as a pivotal framework in the design and analysis of clinical trials, offering a systematic approach for updating evidence as new data become available. By utilising ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...

In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.

We review Bayesian and Bayesian decision theoretic approaches to subgroup analysis and applications to subgroup-based adaptive clinical trial designs. Subgroup analysis refers to inference about ...

Cytel Inc., an advanced analytics leader providing quantitative insights to decision-makers in clinical investigation, has announced the launch of East Alloy®. This new platform is a web-native ...

Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study We divided the borrowing ...